The International Society for Pharmaceutical Engineering announced that the Novartis-Penn Center for Advanced Cellular Therapies has received honorable mention in its Facility of the Year Awards (FOYA) program.
This premier global awards program recognizes innovation and creativity in manufacturing facilities serving the healthcare industry. Projects selected for the FOYA program set the standard for pharmaceutical facilities of the future by demonstrating excellence in facility design, construction, and operations.
“We are proud to honor these organizations that share ISPE’s commitment to innovate and advance pharmaceutical manufacturing technology for the benefit of all global patients,” said John Bournas, ISPE CEO and President.
The jury praised the project, stating:
The facility leverages pharmaceutical engineering principles to successfully merge academic, corporate, and medical considerations thereby creating an innovative center to advance personalized medicine.
The 2017 FOYA Category Winners will be formally recognized at the ISPE Facility of the Year Awards Banquet on 6 June 2017, in Arlington, VA.